VV169, an experimental cellular therapy being developed by Vyriad to treat myeloma, is expected to enter…
Articles by Marisa Wexler, MS
Immuneering is preparing to launch a Phase 3 clinical trial to test its experimental…
The first participant has been dosed in an early clinical trial testing the experimental radiation therapy Alpha DaRT in people…
A Phase 1 clinical trial testing the experimental therapy IDE034 in people with various types of cancer, including gynecological…
Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two…
ELI-002 7P, an experimental anticancer vaccine designed to induce the immune system to attack a specific cancer protein, can also…
Treatment with the experimental medication eflornithine in combination with the approved chemotherapy Gleostine (lomustine) may help improve survival in people…
Dosing has begun in a Phase 3 clinical trial testing Enhertu (trastuzumab deruxtecan) as a maintenance treatment for certain people…
Most people with hard-to-treat myeloma were still alive and free from disease progression two years after treatment with anito-cel…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the experimental medicine CLN-049, which is being…